Oncogenic Signaling by Leukemia-Associated Mutant Cbl Proteins

Scott Nadeau^1,2, Wei An^1,2, Nick Palermo¹, Dan Feng¹, Gulzar Ahmad^1,3,6,7, Lin Dong¹, Gloria E. O. Borgstahl^1,3,6,7, Amarnath Natarajan^1,2,7, Mayumi Naramura^1,2,7, Vimla Band^1,2,3,7 and Hamid Band^1,2,3,4,5,7*

¹Eppley Institute for Research in Cancer and Allied Diseases, USA

²Departments of Genetics, Cell Biology & Anatomy, University of Nebraska Medical Center, 985950 Nebraska Medical Center Omaha, NE 68198-5950, USA

³Departments of Biochemistry & Molecular Biology, University of Nebraska Medical Center, 985950 Nebraska Medical Center Omaha, NE 68198-5950, USA

⁴Department of Pathology and Microbiology, University of Nebraska Medical Center, 985950 Nebraska Medical Center Omaha, NE 68198-5950, USA

⁵Departments of Pharmacology & Experimental Neuroscience, College of Medicine, University of Nebraska Medical Center, 985950 Nebraska Medical Center Omaha, NE 68198-5950, USA

⁶Departments of Pharmaceutical Sciences, College of Pharmacy, University of Nebraska Medical Center, 985950 Nebraska Medical Center Omaha, NE 68198-5950, USA

⁷UNMC-Eppley Cancer Center, University of Nebraska Medical Center, 985950 Nebraska Medical Center Omaha, NE 68198-5950, USA

^*Corresponding Author: